Peer support community for people with neuroendocrine cervical cancer
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
This project will test whether joining a technology-based peer support community helps adults with neuroendocrine cervical cancer feel less isolated and improve emotional well-being and illness perception.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT07532954 on ClinicalTrials.gov |
What this trial studies
This observational program enrolls adults with histologically confirmed neuroendocrine cervical cancer who can use a computer or smartphone; participants join a technology-based peer support community and complete questionnaires about their experiences. The primary aim is to see if participation changes illness perception, emotional wellbeing, and feelings of isolation. Secondary aims include understanding effects on communication with healthcare providers, coping strategies, acceptability of the support format, and identifying unmet needs. Data are collected via questionnaires without any drug or device intervention.
Who should consider this trial
Good fit: Adults aged 18 or older with histologically confirmed neuroendocrine cervical cancer who are English-proficient, able to consent, and have access to a smartphone or computer with internet.
Not a fit: People who prefer in-person support, cannot use the required technology, are not English-proficient, or have severe uncontrolled psychiatric conditions may not receive benefit from this online support format.
Why it matters
Potential benefit: If successful, the peer support community could reduce isolation and improve coping and communication for people living with NECC.
How similar studies have performed: Peer support interventions have shown benefits for emotional well-being and isolation in other cancer populations, but NECC-specific data are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Eligibility Criteria * Histologically confirmed NECC. * Aged 18 years or older. * English proficient. * Provision of signed and dated informed consent form. * Stated willingness to comply with all study procedures and availability for the duration of the study. * Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access). Exclusion Criteria None
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Larissa Meyer, MD — M.D. Anderson Cancer Center
- Study coordinator: Larissa Meyer, MD
- Email: lmeyer@mdanderson.org
- Phone: Meyer
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.